Anavex Life Sciences Corp. Announces its Preclinical Pipeline of Novel Oncology Therapies

Geneva, Switzerland — February 12, 2007 — Anavex Life Sciences Corp. (the “Company”) (OTCBB: AVXL) announces its strategic vision for growth by discovering and developing cutting-edge drugs against solid tumors. The Company’s innovative drug discovery and development programs have helped build a strong pipeline that targets a wide range of solid tumors, including colorectal, prostate,…